{"id":"NCT01536405","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)","officialTitle":"A Phase III Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06-05","primaryCompletion":"2013-07-02","completion":"2014-01-27","firstPosted":"2012-02-22","resultsPosted":"2014-07-02","lastUpdate":"2018-10-31"},"enrollment":1412,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Measles","Mumps","Rubella","Varicella"],"interventions":[{"type":"BIOLOGICAL","name":"MMRV (AMP)","otherNames":[]},{"type":"BIOLOGICAL","name":"MMRV (2006 process)","otherNames":["ProQuadâ„¢"]}],"arms":[{"label":"MMRV (AMP)","type":"EXPERIMENTAL"},{"label":"MMRV (2006 process)","type":"ACTIVE_COMPARATOR"}],"summary":"This study will compare the safety, tolerability, and immunogenicity of measles, mumps, rubella, and varicella (MMRV) vaccine made with an alternative manufacturing process with those of the 2006 process","primaryOutcome":{"measure":"Percentage of Participants With Varicella Zoster Virus (VZV) Antibody Levels >=5 gpELISA Units/mL","timeFrame":"Six weeks after vaccination 1","effectByArm":[{"arm":"MMRV (AMP)","deltaMin":97.3,"sd":null},{"arm":"MMRV (2006 Process)","deltaMin":93,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000","p":"<0.001"}]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["27149048"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":682},"commonTop":["Pyrexia","Injection site erythema","Injection site pain","Upper respiratory tract infection","Injection site swelling"]}}